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L. Blomgren,1* M. Edvinsson,2 E. Hjelm,3 G. Friman2 and D. Bergqvist41Department of Surgery, Capio St Go¨rans Hospital, Stockholm, 2Infectious Diseases, 3Clinical Bacteriology,
Department of Medical Sciences, and 4Department of Surgery, University Hospital, Uppsala, SwedenThe pathophysiology in varicose veins (VV) and the development of venous ulceration (VU) is still unknown. The presence
of Chlamydophila pneumoniae (Cp), cytomegalovirus (CMV) and herpes simplex virus (HSV) has been associated with
arterial disease. The aim of this study was to investigate if this also applies to venous disease. Antibodies to Cp were
determined in 20 patients with VU and three matched groups: controls, VV patients with and without skin changes. PCR
analyses for Cp, CMV and HSV were made from tissue samples taken at surgery for inguinal hernia and VV, 10 patients
each. There was no difference in prevalence of Cp IgA or IgG between the control group and the three groups with VV and
VU. CMV-PCR was positive in three normal veins and in two varicose veins. No Cp- or HSV-specific DNA was found in
any of the tissue samples.Keywords: Varicose veins; Venous ulcer; Chlamydophila pneumoniae; Cytomegalovirus (CMV); Herpes simplex virus
(HSV).Introduction
Varicose veins (VV), chronic venous insufficiency (CVI)
and venous ulceration (VU) are common and a burden
for society and patients, but their etiology is still
unclear.1 Venous surgery can cure many but not all.2
In the pathogenesis of atherosclerosis, studies suggest a
role for Chlamydophila pneumoniae (Cp) and hopes have
been raised that antibiotics may lower cardiovascular
incidents.3 A few studies implicate cytomegalovirus
(CMV) and herpes simplex virus (HSV).4,5 If microbial
agents can be shown to be involved in the development
of CVI, antimicrobial therapy might be an alternative
way to prevent and treat VU.Report
The study was divided in two parts:
Part 1. Serology for Cp was taken from 20 patients
with VU and from an equal number age and sexing author. L. Blomgren, MD, Department of Surgery,
an’s Hospital, SE-112 81 Stockholm, Sweden.
: lena.blomgren@telia.com
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with no VV, VV patients without skin changes, and VV
patients with skin changes but no ulceration. The
mean age was 65 years. Immunoglobulin A and G
class antibodies to Cp were measured using a
microimmunofluorescence assay.6 We found no differ-
ence in the prevalence of IgA or IgG between the
control group and any of the three groups with CVI.
However, in all four groups there was a higher
prevalence of IgA and a lower prevalence of IgG
compared to a reference population of 50 healthy
Swedish blood donors (mean age 50 years).
Part 2. PCR analyses for Cp, CMV and HSV were
performed on tissue samples taken from 10 VV
patients and 10 patients admitted for an inguinal
hernia repair. Only two of the VV patients had
hypostatic skin changes. Five millimeters of a branch
of the external pudendal artery and a normal vein
were excised during the dissection. Arterial samples
were obtained from eight VV patients and five
inguinial hernia patients. A sample of a varicose vein
was taken in VV patients. No Cp- or HSV-specific
DNA was found in any of the tissue samples. We
found no difference between the groups: CMV-PCREJVES Extra 11, 16–17 (2006)
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hernia patients and in two varicose veins from VV
patients.
The study was approved by the Ethics Committee
at the Karolinska University Hospital, Stockholm.Discussion
The exact pathophysiology in the development of VU
is still unknown. A high concentration of white blood
cells (WBC) have been shown in periulcer skin, and it
has been postulated that WBC are trapped by the
venous stasis, activated and thus releasing enzymes
that can cause tissue damage.7 Also in the develop-
ment of VV, aggregates of WBC have been observed in
the vessel wall, possibly as part of a chronic
inflammatory process weakening the vein.8,9 It can
be assumed that these two distinct but linked
processes are multifactorial. One plausible expla-
nation for the presence of WBC is an infection. Cp,
HSV and CMV have been linked to atherosclerosis.
This study could not confirm a possible link with
venous disease. The prevalence of antibodies to Cp in
the study groups differed from that of a reference
group of healthy blood donors, but this may be due to
the fact that the patients were older; Cp positivity
increases with age.6 Whether these negative findings
are true findings, or due to lack of sensitive diagnostic
tests, or to targeting the wrong micro-organisms, is
open to further discussion.10Acknowledgements
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